BEGIN:VCALENDAR
VERSION:2.0
PRODID:icalendar-ruby
CALSCALE:GREGORIAN
X-WR-CALNAME:MPH Capstone Defense: Khang Nguyen 
X-WR-TIMEZONE:Eastern Time (US & Canada)
BEGIN:VEVENT
DTSTAMP:20260815T104406Z
UID:tag:localist.com\,2008:EventInstance_46984469771513
DTSTART:20240718T150000Z
DTEND:20240718T160000Z
DESCRIPTION:Title: Factors Associated With Serious Adverse Events and Misus
 e of Glp-1 Receptor Agonists \n\nChair: Dr. Alexander Kirpich \n\nAbstract
 : This study investigates the factors associated with the serious adverse 
 event (SAE) outcomes and misuse of GLP-1 Receptor Agonists (GLP-1RAs)\, a 
 prominent medication for type-2 diabetes and obesity\, using data from the
  FDA Adverse Event Reporting System (FAERS) from 2005 to 2023. With projec
 ted increases in GLP-1RA use by 2025 and growing concerns about misuse and
  counterfeit products\, more research is needed to understand these risk f
 actors. Using multinomial logistic regression for SAE outcomes and logisti
 c regression for misuse on a sample of 20\,704 reports\, the study found t
 hat each additional year in age decreased the odds of non-fatal SAEs\, fem
 ales had lower odds of fatal SAEs\, and Semaglutide was associated with hi
 gher odds of death/life-threatening outcomes. Misuse was linked to higher 
 odds of hospitalization\, with reports submitted by female consumers had i
 ncreasing misuse odds\, while older age reduced these odds. Thus\, these f
 indings highlight a need for age- and gender-specific risk assessment in G
 LP-1RA therapy. While the study's strengths include its relatively large s
 ample size and statistical approaches\, limitations such as potential repo
 rting bias could warrant further research using more comprehensive data so
 urces. The increasing utilization of GLP-1RAs and associated SAEs necessit
 ate attention from public health agencies\, particularly given the ongoing
  development of more convenient administration methods.
LOCATION:
SUMMARY:MPH Capstone Defense: Khang Nguyen 
URL;VALUE=URI:https://calendar.gsu.edu/event/mph-capstone-defense-khang-ngu
 yen
END:VEVENT
END:VCALENDAR